SUTTER INSTRUMENT CORP

Sutter Instrument Corp specializes in the design, manufacturing, and support of precision analytical laboratory instruments for advanced biomedical research. Their core capabilities center on high-accuracy piezo-driven microsurgery tools, horizontal pipette pullers, and integrated systems for two-photon imaging, all engineered for reproducibility in neuroscience, electrophysiology, and cellular manipulation applications. The company provides not only hardware but also software ecosystems, including Igor Pro integration, enabling seamless data acquisition and control for complex experimental workflows. Their technical differentiation lies in custom-engineered electromechanical systems that meet the stringent demands of peer-reviewed research environments, with a focus on reliability, micron-level precision, and compatibility with existing lab infrastructure. Sutter Instrument Corp maintains a strong, sustained relationship with the Department of Health and Human Services, consistently supplying mission-critical instrumentation for NIH-funded laboratories and research centers. They also serve the Department of Commerce, particularly through software licensing and computational tool renewals tied to scientific data analysis platforms. These engagements reflect long-term, repeat procurement patterns indicative of trusted vendor status within federal research ecosystems. The company’s primary industry focus is analytical laboratory instrument manufacturing, specifically serving life sciences and neurobiology sectors. Their products enable cutting-edge techniques such as patch-clamp electrophysiology and high-resolution neural imaging, positioning them as a niche supplier to academic, government, and biotech research institutions requiring calibrated, non-commodity equipment. Sutter Instrument Corp is a small, privately held entity based in Novato, California, with no federal certifications on record. Their market presence is defined by technical specialization rather than scale, serving a highly focused segment of the federal research infrastructure through direct, product-driven engagements with federal laboratories.